Trial NCT03077698

View at ClinicalTrials.gov 
Org. Study IDs: VX-EC-2-02

Last trial update was posted on 2022-06-07

MeSH Interventions

10-carboxymethyl-9-acridanone Megestrol Megestrol Acetate Progestins

MeSH Conditions

Endometrial Neoplasms

Other Conditions

Endometrial Cancer

Stopping Reasons

The study was discontinued due to a change in development strategy and not due safety concern.

Limitations And Caveats

The study was discontinued early due to a change in development strategy and not due safety concern. No safety concerns were noted during the trial. This change in development strategy was the determining factor in the decision to discontinue the study. Because the study was terminated early, the planned analysis was not conducted, as full enrollment was not met.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID